Lv31
284 积分 2021-05-08 加入
Targeting Hypoxia and Autophagy Inhibition via Delivering Sonodynamic Nanoparticles With HIF‐2α Inhibitor for Enhancing Immunotherapy in Renal Cell Carcinoma
5小时前
待确认
Refining neoadjuvant therapy clinical trial design for muscle-invasive bladder cancer before cystectomy: a joint US Food and Drug Administration and Bladder Cancer Advocacy Network workshop
1个月前
已完结
Perioperative Durvalumab with Neoadjuvant Chemotherapy in Operable Bladder Cancer
1个月前
已完结
Adjuvant Pembrolizumab versus Observation in Muscle-Invasive Urothelial Carcinoma
1个月前
已完结
Neoadjuvant gemcitabine–cisplatin plus tislelizumab in persons with resectable muscle-invasive bladder cancer: a multicenter, single-arm, phase 2 trial
2个月前
已完结
Activity of Enfortumab Vedotin and Sacituzumab Govitecan with Radiation in Preclinical Models of Bladder Cancer
2个月前
已完结
Single-cell Atlas of Penile Cancer Reveals TP53 Mutations as a Driver of an Aggressive Phenotype, Irrespective of Human Papillomavirus Status, and Provides Clues for Treatment Personalization
2个月前
已完结
Checkpoint Inhibitors in Urothelial Carcinoma—Future Directions and Biomarker Selection
2个月前
已完结
Immunotherapy for advanced or metastatic urothelial carcinoma
2个月前
已完结
Clinical and Genomic Landscape of FGFR3-Altered Urothelial Carcinoma and Treatment Outcomes with Erdafitinib: A Real-World Experience
2个月前
已完结
皖公网安备34019202002308
